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B Lymphocytes from Patients
with Tuberculosis Exhibit
Hampered Antigen-Specific
Responses with Concomitant
Overexpression
of Interleukin-8
To the Editor—Tuberculosis due to My-
cobacterium tuberculosis is 1 of the 3 major
killers among infectious diseases. Deci-
phering the interactions between M. tu-
berculosis and the innate and adaptive im-
mune compartments of the host is critical
for understanding the pathogenesis of tu-
berculosis and for designing effective im-
munotherapeutic interventions. By use of
a juvenile rhesus monkey model, Qiu et
al recently demonstrated that severe tu-
berculosis induces unbalanced up-regu-
lation of the immune gene networks of
inflammatory cytokines, chemokines, and
their receptors, but low levels of T cell
responses specific to purified protein de-
rivative [1]. The authors conclude that the
overexpression of immune genes after tu-
berculosis infection favors inflammation
and suppression of antigen-specific T cells.
B lymphocytes, along with T cells, con-
stitute the adaptive immune compart-
ment. In addition to producing antibod-
ies, B cells act as antigen presenting cells
and can produce various inflammato-
ry and immunoregulatory cytokines and
chemokines [2]. Thus, B cells have a pleth-
ora of functions that regulate the course
of immune response and inflammation.
B cells have been shown to be present at
the site of granulomatous reactions dur-
ing tuberculosis infection in both mice
and humans [3]. Therefore, in view of
the latest report on decreased tubercu-
losis antigen–specific T cell responses af-
ter severe tuberculosis, we aimed to de-
cipher antigen-specific B cell responses
and their inflammatory cytokine profiles
in patients with tuberculosis.
Peripheral blood mononuclear cells
were isolated from heparinized blood
samples obtained from healthy donors
and patients with pulmonary tuberculosis.
These patients had clinical symptoms of
tuberculosis and positive tuberculin skin
test results, and the presence of acid-fast
bacilli was verified in sputum samples.
Blood samples were collected after obtain-
ing written informed consent, using pro-
tocols approved by our institutional ethics
committee. B lymphocytes were isolated
from peripheral blood mononuclear cells
by using CD19 beads (Miltenyi Biotech).
Purified B cells were stimulated with either
the total membrane fraction of M. tuber-
culosis strain H37Rv (Colorado State Uni-
versity [National Institute of Allergy and
Infectious Diseases, National Institutes of
Health; Tuberculosis Research Materials
contract N01-AI-40091]) or with lipo-
polysaccharide (from Escherichia coli).
B cells from healthy donors proliferat-
ed in response to stimulation by total
membrane antigens of M. tuberculosis
(figure, panel A). Interestingly, similar
to the report of low levels of antigen-
specific T cell responses, B cells from pa-
tients with tuberculosis showed signifi-
cantly suppressed antigen-specific re-
sponses (figure, panel B). However, B
cells obtained from these patients are not
intrinsically defective and are able to re-
spond to mitogenic stimuli (lipopolysac-
charide). Together, our results suggest
that severe tuberculosis is associated
with hampered antigen-specific B cell
responses in patients.
We then analyzed the cytokines pro-
duced in response to the stimulation of B
cells with total membrane fractions of
H37Rv. We found that the patients’ B cells
produce an increased amount of the in-
flammatory cytokines interleukin (IL)–8
and IL-6 ( , by use of the Student’sPp .09
t test), with no significant changes in the
levels of IL-1b, IL-12 p70, IL-10, or tumor
necrosis factor (figure, panel C). These ob-
servations suggest that severe tuberculosis
induces the up-regulation of B cell inflam-
matory cytokines but low levels of anti-
gen-specific B cell responses. Interestingly,
the presence of IL-8 messenger RNA has
been demonstrated in M. tuberculosis–in-
fected tissues, and IL-8 is one of the im-
portant chemokines involved in cellular
recruitment to the tuberculosis granuloma
[4]. It has also been demonstrated that IL-
8 concentrations in plasma are higher in
patients who died from tuberculosis than
in patients who survive tuberculosis, and
hence, it can be concluded that IL-8 is
associated with the severity of tuberculosis
[5]. Our results suggest that B cells con-
tribute to the to high levels of IL-8 ob-
served in tuberculosis patients.
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Figure. Lymphoproliferation and cytokine secretion of human B cells in response to total membrane antigens of Mycobacterium tuberculosis H37Rv.
B cells from 3 purified protein derivative–positive healthy donors (A) and 3 patients with tuberculosis (B) were assayed for the proliferative response
to total membrane fraction of H37Rv. Purified B cells were cultured at a concentration of cells/well/200 mL in the presence of RPMI 1640,42.5 10
10% fetal calf serum, and 10 mg/mL of F(ab′)2 fragments of rabbit anti–human IgM antibodies alone (control [Ctr]), with 5 mg/mL total membrane
antigens (H37Rv), or with 1mg/mL lipopolysaccharide (LPS) in 96-well, round-bottomed plates for 5 days. After 4 days, the cells were pulsed for 16
h with 37 GBq of [3H]-thymidine to quantify B cell proliferation. Radioactive incorporation was measured by standard liquid scintillation counting, and
the results were expressed as counts per minute (mean  standard error of quadruplicate values). Statistical significance for the comparison to Ctr
is indicated (* , by use of the Student’s t test). C, The secretion of cytokines (in picograms per milliliter) in cell-free supernatants, as analyzedP ! .05
by cytokine bead array assay (BD Biosciences). Mean values are indicated with a horizontal bars. CPM, counts per minute; IL, interleukin; TNF, tumor
necrosis factor.
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